Drug class
Bone Formation Stimulating Agents - Natriuretic Peptide
"Bone Formation Stimulating Agents - Natriuretic Peptide" is a commercial compendia and formulary classification, rather than a standardized FDA-established drug class, used primarily to categorize C-type natriuretic peptide (CNP) analogs such as vosoritide. Read more about Bone Formation Stimulating Agents - Natriuretic Peptide
2 drugs in this class 2 manufacturers
Drugs in Bone Formation Stimulating Agents - Natriuretic Peptide
YUVIWEL (navepegritide)
"Bone Formation Stimulating Agents - Natriuretic Peptide" is a commercial compendia and formulary classification, rather than a standardized FDA-established drug class, used primarily to categorize C-type natriuretic peptide (CNP) analogs such as vosoritide.
These therapeutic agents act by binding directly to the natriuretic peptide receptor-B (NPR-B), which inhibits the downstream MAPK/ERK pathway to stimulate endochondral bone growth and chondrocyte proliferation.
Clinically, this category is indicated to promote linear growth in pediatric patients with achondroplasia who have open epiphyses.
-
iehp.org
"Bone Formation Stimulating Agents - Natriuretic Peptide" is a commercial compendia and formulary classification, rather than a standardized FDA-established drug class, used primarily to categorize C-type natriuretic peptide (CNP) analogs such as vosoritide
-
michigan.gov
"Bone Formation Stimulating Agents - Natriuretic Peptide" is a commercial compendia and formulary classification, rather than a standardized FDA-established drug class, used primarily to categorize C-type natriuretic peptide (CNP) analogs such as vosoritide
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.